1. Home
  2. UCTT vs STOK Comparison

UCTT vs STOK Comparison

Compare UCTT & STOK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ultra Clean Holdings Inc.

UCTT

Ultra Clean Holdings Inc.

HOLD

Current Price

$59.46

Market Cap

2.1B

Sector

Technology

ML Signal

HOLD

Logo Stoke Therapeutics Inc.

STOK

Stoke Therapeutics Inc.

HOLD

Current Price

$35.77

Market Cap

2.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
UCTT
STOK
Founded
1991
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Semiconductors
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.1B
2.0B
IPO Year
2004
2019

Fundamental Metrics

Financial Performance
Metric
UCTT
STOK
Price
$59.46
$35.77
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
10
Target Price
$75.00
$36.10
AVG Volume (30 Days)
1.2M
566.7K
Earning Date
01-01-0001
04-15-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
30.67
EPS
N/A
0.85
Revenue
$1,734,500,000.00
$36,555,000.00
Revenue This Year
$8.52
$430.19
Revenue Next Year
$15.30
N/A
P/E Ratio
N/A
$41.76
Revenue Growth
N/A
316.34
52 Week Low
$16.66
$5.35
52 Week High
$73.80
$38.62

Technical Indicators

Market Signals
Indicator
UCTT
STOK
Relative Strength Index (RSI) 59.13 63.53
Support Level $22.71 $30.50
Resistance Level N/A $37.98
Average True Range (ATR) 4.71 2.05
MACD 0.61 0.44
Stochastic Oscillator 49.86 72.82

Price Performance

Historical Comparison
UCTT
STOK

About UCTT Ultra Clean Holdings Inc.

Ultra Clean Holdings Inc, through its subsidiaries, manufactures and supplies production tools, modules, and subsystems for the semiconductor capital equipment industry. The product includes precision robotic solutions, gas delivery systems, and a variety of industrial and automation production equipment products; subsystems include wafer cleaning subsystems, chemical delivery modules, top-plate assemblies, frame assemblies, and process modules. Its customer base includes firms in the semiconductor capital equipment industry, medical, energy, industrial, flat panel, and research equipment industries. It has two segments Products and Services. Its principal markets are Americas, Asia Pacific and EMEA.

About STOK Stoke Therapeutics Inc.

Stoke Therapeutics Inc is a biotechnology company dedicated to restoring protein expression by harnessing the body's potential with RNA medicine. Its proprietary TANGO (Targeted Augmentation of Nuclear Gene Output) approach, Stoke is developing antisense oligonucleotides (ASOs) to restore naturally-occurring protein levels selectively. Its first medicine in development, zorevunersen, has demonstrated the potential for disease modification in patients with Dravet syndrome. The company provides early programs focused on multiple targets, including haploinsufficiency diseases of the central nervous system and eye, to up-regulate the protein expression of the underlying disease gene in a mutation-agnostic manner.

Share on Social Networks: